ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,359.91
0.13%
Dow Jones
38,940.55
0.14%
US Dollar vs MXN
18.35371
2.61%
Brent Oil
79.395
-0.61%
Bitcoin
69,133.73
-2.30%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Biogen Inc (BIIB)

  7. Biogen Inc (BIIB) Noticias

BIIB

Biogen (BIIB)

Biogen Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BIIB
FechaHoraFuenteTítuloSímboloCompañía
05/06/202404:45PR Newswire (US)Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class Action - BIIBNASDAQ:BIIBBiogen Inc
04/06/202408:10IH Market NewsEconomic Worries May Lead To Weakness On Wall StreetNASDAQ:BIIBBiogen Inc
03/06/202406:30GlobeNewswire Inc.Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air TravelNASDAQ:BIIBBiogen Inc
30/05/202415:51GlobeNewswire Inc.Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALSNASDAQ:BIIBBiogen Inc
23/05/202406:40IH Market NewsOpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More NewsNASDAQ:BIIBBiogen Inc
22/05/202406:30GlobeNewswire Inc.Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology BiosciencesNASDAQ:BIIBBiogen Inc
16/05/202406:30GlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisNASDAQ:BIIBBiogen Inc
16/05/202406:30PR Newswire (US)Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisNASDAQ:BIIBBiogen Inc
14/05/202418:33GlobeNewswire Inc.Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track StatusNASDAQ:BIIBBiogen Inc
14/05/202418:30PR Newswire (US)Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track StatusNASDAQ:BIIBBiogen Inc
02/05/202406:30GlobeNewswire Inc.Biogen Reports Progress on Corporate Responsibility PrioritiesNASDAQ:BIIBBiogen Inc
31/03/202418:30PR Newswire (US)Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDANASDAQ:BIIBBiogen Inc
06/03/202406:30GlobeNewswire Inc.New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene TherapyNASDAQ:BIIBBiogen Inc
04/03/202415:15GlobeNewswire Inc.Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual MeetingNASDAQ:BIIBBiogen Inc
26/02/202418:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIIBBiogen Inc
23/02/202406:00GlobeNewswire Inc.Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMPNASDAQ:BIIBBiogen Inc
22/02/202409:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BIIBBiogen Inc
13/02/202406:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIIBBiogen Inc
12/02/202418:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIIBBiogen Inc
12/02/202415:06GlobeNewswire Inc.Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s AtaxiaNASDAQ:BIIBBiogen Inc
09/01/202416:52Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIIBBiogen Inc
19/12/202306:30GlobeNewswire Inc.Centralized Marketing Authorizations of Generic Versions of TECFIDERA® are Revoked by the European CommissionNASDAQ:BIIBBiogen Inc
15/12/202308:05GlobeNewswire Inc.CHMP Issues Positive Opinion for Biogen’s SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia, a Rare Neurodegenerative DiseaseNASDAQ:BIIBBiogen Inc
14/12/202305:30Business WireZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is Now Available in the U.S.NASDAQ:BIIBBiogen Inc
08/11/202315:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIIBBiogen Inc
08/11/202307:19IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNASDAQ:BIIBBiogen Inc
06/11/202316:44KR Market News월스트리트 상승, 시장은 연준 연사 및 재무부 경매 주목NASDAQ:BIIBBiogen Inc
06/11/202306:30GlobeNewswire Inc.Biogen Appoints Monish Patolawala to its Board of DirectorsNASDAQ:BIIBBiogen Inc
26/10/202306:08IH Market NewsThursday’s Wall Street Highlights: Ford, Morgan Stanley, Align Technology, Endeavor, and moreNASDAQ:BIIBBiogen Inc
25/10/202316:26GlobeNewswire Inc.Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and Clinical Improvement Data in Earlier Stages of Early Alzheimer’s Disease From Additional Analyses of Clarity AD at The Clinical Trials On AlzNASDAQ:BIIBBiogen Inc
 Showing the most relevant articles for your search:NASDAQ:BIIB

Su Consulta Reciente

NYSE
KO
Coca Cola
USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
VZ
Verizon Communications
FX
EURMXN
Euro vs MXN
PM
XAUUSD
Gold vs US Dollar
NYSE
AXP
American Express
USOTC
RHHBY
Roche (QX)
COIN
ETHUSD
Ethereum
AMEX
XLE
Energy Select Sector SPDR
NYSE
CVX
Chevron
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US500
US 500
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados